Price (delayed)
$1,078.495
Market cap
$118.83B
P/E Ratio
29.86
Dividend/share
N/A
EPS
$36.12
Enterprise value
$118.94B
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities , it
There are no recent dividends present for REGN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.